Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: .07? That's it?

"This news should have resulted in a .50 or more move."

As much as I would like to see it, I don't think these 3 signings would warrant a $200 million increase in our market value. That would probably represent 'irrational exhuberance'.

That said, the ball is now in our court, or so it seems. Hopefully we can live up to our potential.

Share
New Message
Please login to post a reply